Blanket Purchase Agreement 36C24126A0010

The Binding Site, Inc. has been awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), with a ceiling value of approximately $1.93 million and a performance period extending through December 14, 2030. This non-competed, sole-source procurement was processed under Federal Acquisition Regulation 13.5 Simplified Procedures for Certain Commercial Items and establishes The Binding Site as the exclusive vendor for specialized medical testing equipment and reagents supporting multiple myeloma diagnostics across VISN 1 medical facilities. The contract specifically covers the supply and support of Optilite Protein Analyzers and associated HevyLITE testing reagents for the identification of free light chain lambda and kappa proteins, as well as immunoglobulin assays. Testing services will be centralized at the West Roxbury VA Immunology laboratory, which will serve all VISN 1 sites. The VA determined that The Binding Site was the sole capable source due to their proprietary technology and FDA-approved polyclonal assays for diagnosing and monitoring multiple myeloma, which are unavailable from competing vendors.

This procurement directly supports enhanced clinical pathology and cancer diagnostic capabilities for the veteran population served by VISN 1, enabling timely identification and monitoring of multiple myeloma through specialized protein analysis. The Binding Site's established role as a critical federal healthcare vendor is reflected in their portfolio of multiple indefinite delivery vehicles across various VA Integrated Service Networks, with contract values ranging from approximately $339,000 to $1.47 million. The agreement reflects the VA's commitment to procuring advanced diagnostic technologies that improve clinical outcomes for veterans while leveraging simplified commercial acquisition procedures appropriate for established medical devices and laboratory reagents.